Literature DB >> 24782602

Gastric cancer research in Mexico: a public health priority.

Clara Luz Sampieri1, Mauricio Mora1.   

Abstract

This study aimed review studies conducted on Mexican patients diagnosed with gastric cancer and/or diseases associated with its development, in which at least one Mexican institute has participated, and to assess their contributions to the primary and secondary prevention of this disease. A search of the Medline database was conducted using the following keywords: gastric/stomach cancer, Mexico. Studies of the Mexican population were selected in which at least one Mexican Institute had participated and where the findings could support public policy proposals directed towards the primary or secondary prevention of gastric cancer. Of the 148 studies found in the Medline database, 100 were discarded and 48 were reviewed. According to the analysis presented, these studies were classified as: epidemiology of gastric cancer (5/48); risk factors and protectors relating to gastric cancer (9/48); relationship between Helicobacter pylori and pathologies associated with gastric cancer and the development of the disease (16/48); relationship between the Epstein-Barr virus and pathologies associated with gastric cancer and the development of the disease (3/48); molecular markers for the development of diseases associated with gastric cancer and gastric cancer (15/48). Mexico requires a program for the prevention and control of gastric cancer based on national health indicators. This should be produced by a multidisciplinary committee of experts who can propose actions that are relevant in the current national context. The few studies of gastric cancer conducted on the Mexican population in national institutes highlight the poor connection that currently exists between the scientific community and the health sector in terms of resolving this health issue. Public policies for health research should support projects with findings that can be translated into benefits for the population. This review serves to identify national research groups studying gastric cancer in the Mexican population.

Entities:  

Keywords:  Gastric cancer; Mexico; Prevention; Public health; Research

Mesh:

Year:  2014        PMID: 24782602      PMCID: PMC4000486          DOI: 10.3748/wjg.v20.i16.4491

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  69 in total

1.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

2.  Epidemiologic panorama of stomach cancer mortality in Mexico.

Authors:  V Tovar-Guzmán; C Hernández-Girón; S Barquera; N Rodríguez-Salgado; L López-Carrillo
Journal:  Arch Med Res       Date:  2001 Jul-Aug       Impact factor: 2.235

3.  Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer.

Authors:  Guillermo Ignacio Pérez-Pérez; Francisco Javier Bosques-Padilla; Maria Luisa Crosatti; Rolando Tijerina-Menchaca; Elvira Garza-González
Journal:  Scand J Gastroenterol       Date:  2005-01       Impact factor: 2.423

4.  Family history and the risk of stomach and colorectal cancer.

Authors:  C La Vecchia; E Negri; S Franceschi; A Gentile
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

5.  Dietary intake of polyphenols, nitrate and nitrite and gastric cancer risk in Mexico City.

Authors:  Raúl U Hernández-Ramírez; Marcia V Galván-Portillo; Mary H Ward; Antonio Agudo; Carlos A González; Luis F Oñate-Ocaña; Roberto Herrera-Goepfert; Oswaldo Palma-Coca; Lizbeth López-Carrillo
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

6.  [p53 expression in the gastric mucosa of patients infected with Helicobacter pylori].

Authors:  G A Morales-Fuentes; A Zarate-Osorno; E E Quiñónez-Urrego; M Antonio-Manrique; C L Martínez-García; P Figueroa-Barojas; Y Zamorano-Orozco; S E Leal-Osuna; C Martínez-Camacho; L A Mejía-Cuán; C A Rivera-Nava; X Sánchez-Chávez; M A Ramírez-Ramírez
Journal:  Rev Gastroenterol Mex       Date:  2013-01-29

7.  [Helicobacter pylori infection and its association with alcohol consumption: a case-control study].

Authors:  J A Sánchez-Cuén; A B Irineo Cabrales; G Bernal Magaña; F J Peraza Garay
Journal:  Rev Gastroenterol Mex       Date:  2013-08-08

Review 8.  Clinical aspects of Helicobacter pylori infection.

Authors:  Witold Bartnik
Journal:  Pol Arch Med Wewn       Date:  2008 Jul-Aug

9.  The utility of serologic tests as biomarkers for Helicobacter pylori-associated precancerous lesions and gastric cancer varies between Latin American countries.

Authors:  L Flores-Luna; M Camorlinga-Ponce; G Hernandez-Suarez; E Kasamatsu; M E Martínez; R Murillo; E Lazcano; J Torres
Journal:  Cancer Causes Control       Date:  2012-11-27       Impact factor: 2.506

10.  Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population.

Authors:  Heriberto Medina-Franco; Antonio Ramos-De la Medina; Gloria Vizcaino; Jose Luis Medina-Franco
Journal:  Ann Surg Oncol       Date:  2007-06-05       Impact factor: 5.344

View more
  3 in total

1.  Resources and Costs Associated with the Treatment of Advanced and Metastatic Gastric Cancer in the Mexican Public Sector: A Patient Chart Review.

Authors:  Miguel Quintana; José A Toriz; Diego Novick; Kyla Jones; Brenda S Botello; Juan Alejandro Silva
Journal:  Pharmacoecon Open       Date:  2018-06

2.  Lymph node retrieval in radical gastrectomy: the pathologist alone or the surgeon-pathologist team?

Authors:  Leonardo S Lino-Silva; Hortencia E Mendoza-Lara; Alberto M León-Takahashi; César Zepeda-Najar; Rosa A Salcedo-Hernández
Journal:  Prz Gastroenterol       Date:  2021-09-17

3.  Complete Genome Sequence of Helicobacter pylori Strain 29CaP Isolated from a Mexican Patient with Gastric Cancer.

Authors:  Eduardo Mucito-Varela; Gonzalo Castillo-Rojas; Miguel A Cevallos; Luis Lozano; Enrique Merino; Gamaliel López-Leal; Yolanda López-Vidal
Journal:  Genome Announc       Date:  2016-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.